Hawaii bills · 2026 Regular Session
Hawaii SB 49
RELATING TO TERMINAL ILLNESSES.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
Summary
Official abstract published by the Hawaii legislature· description
Authorizes manufacturers of investigational drugs or biological products that are pending approval by the United States Food and Drug Administration to make the drugs or products available to terminally ill patients under certain conditions. Effective 12/31/2050. (SD1)
Text versions
Roll-call votes
State vote data last updated Oct 17, 2026, 8:12 AM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Jan 29, 2025 Senate | The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. | pass | Set your home in Hawaii to see |
Actions
- Jan 8, 2025 · Senate
Pending Introduction. - Jan 15, 2025 · Senate
Introduced and passed First Reading. - Jan 16, 2025 · Senate
Referred to HHS, CPN/JDC. - Jan 24, 2025 · Senate
The committee(s) on HHS has scheduled a public hearing on 01-29-25 1:00PM; Conference Room 225 & Videoconference. - Jan 29, 2025 · Senate
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none. - Feb 7, 2025 · Senate
Reported from HHS (Stand. Com. Rep. No. 90) with recommendation of passage on Second Reading, as amended (SD 1) and referral to CPN/JDC. - Feb 7, 2025 · Senate
Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPN/JDC. - Dec 8, 2025 · Legislature
Carried over to 2026 Regular Session.